Abstracts 2012-2021

2021

206.Goldenberg R, Færch L, Horn D, Jain A, Jeppesen O.K, Khunti K , Pakseresht A, L. Perreault L,Tahrani A, Viljoen A,  Jacob S. Effect of semaglutide 2.4 mg on achievement of weight loss and HbA1c <7%, without hypoglycaemia, in adults with overweight/obesity and type 2 diabetes in STEP 2. 57th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Vitual meeting, 27 |September-1 October 2021. Diabetologia (2021) 64 (Suppl 1):S1–S380. Doi : 10.1007/s00125-021-05519-y

205.Khunti K, Hindsberger C, Lawson J, Vrhnjak B, Le Roux C. Greater Proportions of Subjects Achieved HbA1c <7% without Weight Gain, Hypoglycemia, or Moderate/Severe Gastrointestinal Adverse Events with Semaglutide vs. Comparators in the SUSTAIN 7-10 Trials. American Diabetes Association’s 81st Scientific Session. Diabetes 2021 Jun 25-29; 70 (Supplement 1): 666-P Doi: 10.2337/db21-666-P.

204. Arnold SV, Tang F, Cooper A, Chen H, Gomes MB, Rathmann W, Shimomura I, Vora J, Watada H, Khunti K, Kosiborod MN.Global Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: Results from DISCOVER. American Diabetes Association’s 81st Scientific Session. Diabetes 2021 Jun 25-29; 70 (Supplement 1):324-OR. Doi: 10.2337/db21-324-OR

2020

203 Kadicheeni M, Minhas J, Coles B, Eveson D, Hussain S, Khunti K, Mistri A, Robinson T. MORTAILITY IN THE TIA CLINIC. INTERNATIONAL JOURNAL OF STROKE. SAGE PUBLICATIONS LTD.2020 Nov. 15(1) Suppl 1 : 596.

202. Harris S, Snoek FJ, Meneghini LF, Lauand F, Westerbacka J, de Climens AR, Khunti K.Treatment satisfaction in people with type 2 diabetes receiving basal insulin: results from real-world and randomised controlled studies with insulin glargine 300 U/ml. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR,21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S331.Doi :10.1007/s00125-020-05221-5. PMID :32840677

201. Ling J, Montvida O, Xue C, Khunti K, Paul S. Therapeutic inertia in management of hypertension and dyslipidaemia in young-onset type 2 diabetes and the risk factor burden: evidence from UK primary care. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S148. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

200. Davies MJ, Baldry EL, Bodicoat DH, Chatterjee S, Edwardson CL, Gray LJ, Khunti K, Sargeant JA, Stensel DJ, Webb DR, Wilding JPH, Willis SA, Yates T, King JA. The SGLT2 inhibitor empagliflozin does not stimulate compensatory appetite responses in patients with excess adiposity and type 2 diabetes. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S116. Doi: 10.1007/s00125-020-05221-5. PMID :32840677

199. Kosiborod M, Cooper A, Fenici P, Khunti K, Nicolucci A, Ramirez L, Sia J, Vasnawala H, Wei J, Lam C. The DISCOVER Global Registry: a long term, large scale patient registry of routine care for people with type 2 diabetes. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S140-141. Doi: 10.1007/s00125-020-05221-5. PMID :32840677

198 Abner S, Coles B, Zaccardi F, Seidu S, Gillies C, Davies MJ, Hvid C, Khunti K. Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: a retrospective analysis of 8.3 million consultations. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S312-S312. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

197. Seaquist E, Khunti K, Zhang X, Wang Q, Takita Y, Child CJ, Nagai Y, Yan Y, Matsuhisa M. Nasal glucagon reversed insulin-induced hypoglycaemia in adults with diabetes: a pooled analysis. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S355-S355. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

196. Arnold SV, Khunti K, Tang F, Gomes MB, Ji L, Nicolucci A, Shestakova MV, Watada H, Cooper A, Hammar N, Fenici P, Medina J, Kosiborod M. Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: insights from the DISCOVER study. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S141-142. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

195. Heller SR, Pieber TR, Bajaj HS, Jia T, Khunti K, Klonoff DC, Ladelund S, Leiter LA, Wagner L, Philis-Tsimikas A. HbA(1c) levels and rates of hypoglycaemia with insulin degludec U200 and insulin glargine U300 stratified by renal function subgroups: post hoc analysis from the CONCLUDE trial. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S319. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

194. Sargeant JA, King JA, Baldry EL, Bodicoat DH, Edwardson CL, Khunti K, Stensel DJ, Webb DR, Wilding JPH, Yates T, Davies MJ. Effects of empagliflozin, diet, or both on physical activity and sedentary behaviour in people with type 2 diabetes: analyses from the SEESAW trial. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S270-271. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

193. Adan M, Seidu S, Zaccardi F, Khunti K, Webb D, Gillies C, Davies M, Lubwama R, Boss A, Dex T. Characteristics of people with type 2 diabetes newly initiated with basal insulin therapy: a population-based study using CPRD. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S171-S171. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

192. Coles B, Zaccardi F, Hvid C, Davies MJ, Khunti K. Cardiovascular events and mortality in patients newly diagnosed with type 2 diabetes with and without multimorbidity: a real world observational study. 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWOR, 21-25 September 2020.Diabetologia (2020) 63(Suppl 1):S448-S448. Doi: 10.1007/s00125-020-05221-5.PMID :32840677

191. Zaccardi F, Cortese V, Jacquot E, Tyrer F, Seidu S, Davies MJ, Khunti K. Real-world Effectiveness of Glicazide MR vs. Sitalgliptin as Second-line Therapy in People with type 2 Diabetes Uncontrolled on Metformin. 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 Jun 2020 - 16 Jun 2020. DIABETES. AMER DIABETES ASSOC. 69(Supplement 1): P1062. DOI: 10.2337/db20-1062-P.

190. Inzucchi SE,Davies M, Khunti K, Trivedi P, George JT, Zwiener I. Johansen OE, Sattar N. Empagliflozin treatment effects across categories of baseline cardio-metabolic parameters as an add-on to metformin in patients with type 2 diabetes. Journal of the Endocrine Society 2020 May. Volume 4, Issue Supplement_1, April-May 2020, MON-645. DOI: https://Doi.org/10.1210/jendso/bvaa046.414

2019

189.Nickinson A,Coles B, Payne T, Khunti K, Davies R,Sayers R.Missed Opportunities for Limb Salvage in Patient undergoing a Major Amputation :A Cohort Study Using the Clinical Practice  Research Datalink. European Journal of Vascular & Endovascular Surgery 2019 Dec.58 (6) (Suppl 2): e569- e570. DOI: https://Doi.org/10.1016/j.ejvs.2019.09.035.

188.Saboo B, Makkar BM, Chawla R, Seidu S, Khunti K, Kunutsor S, Kumar V, Agarwal S, Ghosh S, Maheshwari A, Panikar V, Sahay R. Predicting  therapeutic inertia in people with type 2 diabetes mellitus managed at the diabetes centers in India. International Diabetes Federation (IDF) World Diabetes Congress 2019, BEXCO, Busan, Korea, 2-6th December 2019, P-0465.

187.Sukumar N, Dallosso H, Bagias C, Shorthose K, Yates T, Davies M. Khunti K, Saranavan P. Distinct risk factor profiles in South Asian and Caucasian women with previous GDM: Baseline from Baby steps trials. International Diabetes Federation (IDF) World Diabetes Congress 2019, BEXCO, Busan, Korea, 2-6th December 2019, P-0863.

186.Koye D, Ling J, Dibato J, Khunti K, Paul S. Temporal trend in young-onset type 2 diabetes: comorbidities, macrovascular and mortality risk: study of UK primary care electronic medical records. 55th annual meeting of the European Association for the study of Diabetes (EASD),Barcelona, Spain,16-20 September 2019.Diabetologia (2019) 62 (Suppl 1):S1-S600 (82).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

185.Philis-Tsimikas A, Klonoff DC, Khunti K, Bajaj HS, Leiter LA, Tutkunkardas D, Troelsen LN, Bak BA, Heller SR, Pieber TR. Reduced risk of hypoglycaemia and lower HbA1c with degludec compared to glargine U300 in insulin-treated patients with type 2 diabetes. 55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain,16-20 September 2019. Diabetologia (2019) 62(Suppl 1):S1-S600 (90).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

184.Arnold SV,Chen H,Gomes MB, Khunti K, Saraiva LG, Medina J, Pocock S, Shestakova MV, Shimomura I,Tang F,Watada H, Ji L, Charbonnel B, Bonnet F, Kosiborod M. Type 2 diabetes and heart failure:insights from the DISCOVER study. 55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain, 6-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (195).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

183.Nicolucci A,Chen H, Fenici P,Gomes MB, Saraiva GL, Medina J, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K, Charbonnel B. Changes in HbA1c and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study. 55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain, 16-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (353).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

182. Klok R,Gulati T, Rajpathak S,Pal S, Yang L, Bandyopadhyay A, Khunti K. Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis. 55th  annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain,16-20 September 2019. Diabetologia (2019) 62 (Suppl S1)-S600 (354).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

181. Inzucchi SE, Khunti K, Fitchett DH, Wanner C, Mattheus M, George JT, Ofstad A, Zinman B. Consistent cardiovascular (CV) benefits from empagliflozin across the spectrum of CV risk factor control: post hoc analysis from EMPA-REG OUTCOME. 55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain,16-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (686).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

180.Gomes M,Tang F,Chen H,Cid-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Shimomura I, Saraiva LG, Nicolucci A.Socioeconomic factors associated with poor glycaemic control (HbA(1c ≥9.0%) in people with type 2 diabetes: the DISCOVER study.55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain, 6-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (815).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

179. Khunti K, Charbonnel B, Cherney D, Gomes MB, Heerspink HJL, Ji L, Medina J, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Kosiborod M, Arnold SV. Type 2 diabetes and chronic kidney disease: insights from DISCOVER. 55th annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain,16-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (1008).DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

178.Vamos EP, Palladino R, Tabak AG, Valabhji J, Khunti K, Majeed A, Millett C. Association of non-diabetic hyperglycaemia and microvascular and macrovascular complications of type 2 diabetes: a retrospective cohort study. 55th  annual meeting of the European Association for the study of Diabetes (EASD), Barcelona, Spain,16-20 September 2019. Diabetologia (2019) 62 (Suppl 1):S1-S600 (1030). DOI: 10.1007/s00125-019-4946-6. PMID: 31384961

177.Arnold SV,  Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Saraiva GL, Medina J, Nicolucci A, Pocock S, Sadikot SM, Shestakova M, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M. Micro- and Macrovascular Events in Patients with T2D Results from the Global DISCOVER Study. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 420-P. https://Doi.org/10.2337/db19-420-P

176.Harris S, Berard L, Westerbacka J, Bosnyak Z, Melas-Melt L, Lauand F SR, Bailey TS, Khunti K. Early Hypoglycemia after Initiation of Second-Generationm Basal Insulin (BI) Analogs: Patient Charactreristics and Clinical Outcomes. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1095-P. https://Doi.org/10.2337/db19-1095-P

175.Berard L, Snoek FJ, Harris SW, Westerbacka J, Bosnyak Z, Melas-Melt L, Khunti K. Treatment Satisfaction with Gla-300, IDeg-100, and Gla-100 in Inuslin-Naïve T2DM: The BRIGHT and EDITION 3 Trials. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1098-P. https://Doi.org/10.2337/db19-1098-P

174.Iglay K, Sawhney B, Rajpathak S, Crutchlow M, Fernandes G, Khunti K. Distribution of Prescribed Dose During the First Year of Metformin Monotherapy in the U.S. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1144-P. https://Doi.org/10.2337/db19-1144-P

173.Paul SK, Koye D, Khunti K, Montvida O. Early vs. Late Initiation of SGLT2 and GLP-1RA for Cardiometabolic Risk Factor Control: A Real-World Study. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Suplement 1): 1207-P. https://Doi.org/10.2337/db19-1207-P

172.Gomes MB, Tang F, Chen H, Cis-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Sadikot SM, Shimomura I, Saraiva GL, Nicolucci A. Socioeconomic Factors Associated with Poor Glycemic Control in People with Type 2 Diabetes: The DISCOVER Study. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1279-P. https://Doi.org/10.2337/db19-1279-P

171.Bongaerts B, Arnold SV, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Jl L, Khunti  K, Kosiborod MN, Saraiva GL, Medina J, NicolucciI A, Pocock S, Sadikot SM, Shestakova MV, Shimomura I, Surmont F, Tang F, Watada H, Rathmann W. Potential Overtreatment of Older Patients with T2D: The Global Discover Study. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1448-P. https://Doi.org/10.2337/db19-1448-P

170.Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Saraiva GL, Medina J, Nicolucci A, Pocock S, Shestakova MV, Shimomura I, Sadikot SM, Surmont F, Tang F, Jiten V, Watada H, Khunti K. Changes in HbA1c and Treatment in the Second Year following Imnitiation of Second-Line Therapy in People with T2D – The Global Discover Study. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Suplement 1): 1628-P. https://Doi.org/10.2337/db19-1628-P

169.Klok RM, Gulati T, Rajpathak S, Pal S, Yang L, Bandyopadhyay A, Khunti K. Role of Initial Combination Therapy on Goal Attainment among Patients with Type 2 Diabetes with High HbA1c. American Diabetes Association’s 79th Scientific Session. Diabetes 2019 Jun; 68 (Supplement 1): 1637-P. https://Doi.org/10.2337/db19-1637-P

168.Harrington D, O’Connell S, Ackroyd C, Gray L, Khunti K, Willis A, Davies MJ. Professional sports club and workplace Type 2 diabetes screening using the Leicester Diabetes Risk Score: Six-monthly results from the Leicester Changing Diabetes Programme. Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (P209). PMID: 30838691

167.Brough C, Schreder S, Northern A, Hadjiconstantinou M, Davies MJ, Khunti K.  Development of a web-based prevention programme for women with post Gestational Diabetes (GDM): Baby Steps.  Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (P210). PMID: 30838691

166.Hadjiconstantinou M, Schreder S, Brough C, Northern A, Stribling B, Troughton J, Khunti K, Davies MJ.  MyDesmond: A digital self-management programme for people living with type 2 diabetes.  Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (P212). PMID: 30838691

165.Mohan V, Cooper ME, Matthews DR, Khunti K. The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm. Diabetes Ther 2019 Mar. 10(Suppl 1):1-13. DOI: 10.1007/s13300-019-0573-y. Epub 2019 Feb 13. PMID: 30758834

164.Spanopoulos D, Okhai H, Zaccardi F, Barrett B, Busse M, Khunti K. Temporal variation of renal function inpatients with Type 2 diabetes: A retrospective cohort study using data from the UK Clinical Practice Research Datalink. Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (P386). PMID: 30838691

163.Gupta P, Mohamed M, Patel P, Burns A, Saeed M, Lane D, Seidu S, Khunti K. Suboptimal adherence rates in people with diabetes: A novel liquid chromatography-tandem mass spectrometry method approach to non-adherence assessment. Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (A12, P102). PMID: 30838691

162.Hussein H, Zaccardi F, Khunti K, Seidu S, Davies MJ, Gray LJ.  Cardiovascular efficacy and safety of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A systematic review and network meta‐analysis.  Diabetes UK Professional Conference 2019, ACC Liverpool, 6-8 March 2019. Diabet Med. 2019 Mar; 36 Suppl 1:5-174. Doi: 10.1111/dme.13882. (P142). PMID: 30838691

2018

161. Khunti K. Therapy adjustment in adult T2DM patients with renal impairment treated with DPP-4 inhibitors in the UK: a retrospective cohort study. ISPOR Europe 2018, Barcelona (13 November 2018). PDB101.

160.Miller EM, Jodar E, Khunti K, Sugimoto D, Orsy P, Ranthe MF, Viljoen A.  The clinical benefits of IDegLira in DUAL VII were achieved while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.  54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (83).Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

159.Fenici P, Bonnet F, Chen H, Cid-Ruzafa J, Gomes MB, Hammar N, Ji L , Kennedy KF, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Charbonnel B.  Change over 12 months in HbA1c, fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER.  54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (294). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

158. Nicolucci A, Gomes MB, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Tang F, Ji L. Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (344). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

157.Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kennedy KF, Pocock S, Shestakova MV, Shimomura I, Surmont F, Ji1 L. Individualised HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (347). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

156.Klok RM, Kumar A, Rajpathak S, Fu AZ, Khunti K. Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (351). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

155.Ji1 L, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Kosiborod M. Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia (2018) 61 (Suppl 1):S1–S620 (638). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

154..Kloecker D, Zaccardi F, Davies MJ, Dario M, Khunti K, Webb D. Efficacy of low- and very-low-calorie diets in overweight and obese patients with type 2 diabetes: a meta-analysis of intervention studies. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia 2018 Oct; 61(Suppl 1):1-620, (679). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

153. Iglay K, Sawhney B, Fu AZ, Fernandes G, Crutchlow M, Rajpathak S, Khunti K. Distribution of dose and up-titration patterns for patients initiating metformin monotherapy in the UK. 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia 2018 Oct; 61(Suppl 1):1-620, (705). Doi: 10.1007/s00125-018-4693-0. PMID: 30132038

152. Berard L, Mauricio D, Khunti K, Franco DR, Westerbacka J, Candelas C, Pilorget V, Perfetti R, Meneghini L.  Achievement of individual HbA1c targets with self- vs physician-led titration of newly or recently initiated basal insulin in type 2 diabetes: DUNE real-world study results.  54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia 2018 Oct;61(Suppl 1):1-620, (824).  Doi: 10.1007/s00125-018-4693-0.  PMID: 30132038

151.Gupta P, Mohamed AA, Patel P, Burns A, Saeed M, Lane D, Seidu S, Khunti K.  A novel liquid chromatography tandem mass spectrometry method detects high non-adherence rates in people with diabetes.  54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia 2018 Oct;61(Suppl 1):1-620, (886).  Doi: 10.1007/s00125-018-4693-0.  PMID: 30132038

150. Surmont F, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Ji L, Hammar N, Kosiborod M.  54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Germany, 01 Oct 2018 - 05 Oct 2018. Diabetologia 2018 Oct;61(Suppl 1):1-620, (1150).  Doi: 10.1007/s00125-018-4693-0.  PMID: 30132038

149. Mauricio D, Meneghini L, Orsi E, Klimontov V, Westerbacka J, Melas-Melt L, Pilorget V, Perfetti R, Khunti K.  Change in Insulin Dose and HbA1c by Geographical Region—Results from the Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) Study. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1037-P. https://Doi.org/10.2337/db18-1037-P

148.Berard L, Mauricio D, Khunti K, Franco D, Westerbacka J, Candelas C, Pilorget V, Perfetti R, Meneghini L.  Achievement of Individualized HbA1c Targets with Self- vs. Physician-Led Titration of Basal Insulin (BI) in People with Type 2 Diabetes (T2DM), Newly or Recently Initiated on BI—Results from the DUNE Real-World Study. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1039-P. https://Doi.org/10.2337/db18-1039-P

147. Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Khunti K, Pocock S, Shestakova M, Shimomura I, Surmont F, Tang F, Ji L. Temporal Trends in the Use of Sodium-Glucose Cotransporter 2 Inhibitors—The Global DISCOVER Study. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1141-P. https://Doi.org/10.2337/db18-1141-P

146.Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes M, Khunti K, Pocock S, Rathmann W, Shestakova M, Shimomura I, Surmont F, Tang F, Watada H, Ji L, Hammar N. Vascular Events in Patients with Type 2 Diabetes in the Year following Initiation of Second-Line Therapy-The DISCOVER Study. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1562-P. https://Doi.org/10.2337/db18-1562-P

145. Charbonnel B, Bonnet F, Chen H, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Ji L, Kennedy K, Kosiborod M, Pocock S, Rathmann W, Shestakova M, Shimomura I, Surmont F, Khunti K.  Twelve-Month Changes in HbA1c, Fasting Plasma Glucose, and Weight among Patients with Type 2 Diabetes in 37 Countries—DISCOVER. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1615-P. https://Doi.org/10.2337/db18-1615-P

144.Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Kennedy K, Kosiborod M, Pocock S, Shestakova M, Shimomura I, Surmont F, Ji L.  Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy—The Global DISCOVER Study. American Diabetes Association’s 78th Scientific Session. Diabetes 2018 Jul; 67 (Supplement 1): 1629-P. https://Doi.org/10.2337/db18-1629-P

143.Hambling C, Seidu S, Khunti K. Reducing intensive glycaemic management among older people with Type 2 diabetes prescribed sulphonylurea (SU) or insulin therapies. Diabetes UK Professional Conference, London. Diabetic Medicine 2018, 35 (Suppl. 1):6. A5 (Oral Abstract) https://Doi.org/10.1111/dme.13570

142. Holman N, Sattar N, Wild S, Khunti K, Young B. Early-onset Type 2 diabetes is associatedwith higher risk of mortality: An analysis ofthe National Diabetes Audit. Diabetes UK Professional Conference, London. Diabetic Medicine 2018, 35 (Suppl. 1):12. A19 (Oral Abstract) https://Doi.org/10.1111/dme.3_13570

141. Woolley A, Seidu S, Davies MJ, Khunti K.  Patient education format preferences fordifferent sociodemographic groups in Type2 diabetes and cardiovascular disease. Diabetes UK Professional Conference, London. Diabetic Medicine 2018, 35 (Suppl. 1):134. P317. https://Doi.org/10.1111/dme.33_13571

140.Hambling C, Seidu S, Khunti K. Reducing intensive glycaemic management among older people with Type 2 diabetes prescribed sulphonylurea (SU) or insulin therapies. Diabetes UK Professional Conference, London. Diabetic Medicine 2018, 35 (Suppl. 1):198. P514. https://Doi.org/10.1111/dme.58_13571

139. Holman N, Sattar N, Wild S, Khunti K, Young B. Early-onset Type 2 diabetes is  associated with higher risk of mortality: An analysis ofthe National Diabetes Audit. Diabetes UK Professional Conference, London. Diabetic Medicine 2018, 35 (Suppl. 1):198. P515. https://Doi.org/10.1111/dme.58_13571

2017

138. Zafar A, Khunti K, Jaleel N, Saleem A.  Cross sectional study to look at the factors leading to clinical inertia in UK primary setting in the management of T2DM. International Diabetes Federation (IDF) World Diabetes Congress 2017, Abu Dhabi, UAE. P-0359.

137.Khunti K. The DISCOVER study programme: methods and baseline characteristics. International Diabetes Federation (IDF) World Diabetes Congress 2017, Abu Dhabi, UAE. 188.

136.Rathmann W, Charbonnel B, Gomes M, Hammar N, Khunti K, Kosiborod M,  Kuss O, Shestakova M, Watada H, Shimomura I, Tang F, Ji L.  Factors associated with hypoglycaemia in 12 679 patients starting second-line therapy: the global DISCOVER study. International Diabetes Federation (IDF) World Diabetes Congress 2017, Abu Dhabi, UAE. OP-0101.

135 Pedersen-Bjergaard U, Aronson R, Gydesen H, Barner Lekdorf J, Khunti K.  Hypoglycaemia awareness and risk of severe hypoglycaemia in the Global HAT study of type 1 and type 2 diabetes. International Diabetes Federation (IDF) World Diabetes Congress 2017, Abu Dhabi, UAE. OP-0098.

134 Mani H, Chudasama Y, Bodicoat D, Levy M, Gray L, Howlett T, Khunti K, Davies MJ.  High prevalence of multimorbidity in overweight and obese women with Polycystic Ovary Syndrome (PCOS). Endocrine Abstracts (2017) 50 P370, Doi:10.1530/endoabs.50.P370.

133. Boels A, Vos R, Hermans T, Zuithoff  N, Müller N, Khunti K, Rutten GEH, GUIDANCE study group.  What determines treatment satisfaction of type 2 diabetes patients on insulin therapy? An observational study in eight European countries.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S1–S608 (73), DOI 10.1007/s00125-017-4350-z. PMID:28795195

132.Cavender M, Norhammar A, Birkeland K, Jørgensen M, Wilding J, Khunti K, Fu A, Bodegård J, Blak B, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M, on behalf of the CVD-REAL Investigators and StudyGroup.  Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S41 (88), DOI 10.1007/s00125-017-4350-z. PMID:28795195

131.Adjah E, Montvida O, Khunti K, Paul S.  Interactive changes in cardiovascular risk factors and the long-term cardiovascular risk differ by adiposity levels in incident type 2 diabetes patients: real world study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S1–S608 (166), DOI 10.1007/s00125-017-4350-z. PMID:28795195

130 Teh H, Desai U , Kirson N , Hellstern M, Leigh P, Mukherjee J, Khunti K.  Renal outcomes with DPP-4 inhibitors compared with sulfonylurea as add-on to metformin among patients with type 2 diabetes.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S1–S608 (263), DOI 10.1007/s00125-017-4350-z. PMID:28795195

129.Gomes M, Charbonnel B, Cid-Ruzafa J, Fenici P, Hammar N, Khunti K, Kosiborod M,  Nicolucci A, Pocock S, Shestakova M, Watada H, Shimomura I, Tang F, Ji L.  Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S140 (301), DOI 10.1007/s00125-017-4350-z. PMID:28795195

128.Ji L, Nicolucci A, Arya N, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Kosiborod M, Pocock S, Shestakova M, Watada H, Shimomura I, Tang F, Khunti K.  Glycaemic control in 14,005 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S140–S141 (302), DOI 10.1007/s00125-017-4350-z. PMID:28795195

127.Wilding J, GodecT, Khunti K, Pocock S, Fox R, Smeeth L, Blak B, Clauson P, Fenici P, Hammar N, Rigney U, Medina J.  Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S301 (661), DOI 10.1007/s00125-017-4350-z. PMID:28795195

126.Nicolucci1 A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Khunti K, Kosiborod M, Shestakova M, Watada H, Shimomura I, Tang F, Pocock S.  Treatment patterns and associated factors in 13,379 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S1–S608 (662), DOI 10.1007/s00125-017-4350-z. PMID:28795195

125. Pedersen-Bjergaard U,  Aronson R, Gydesen H, Barner Lekdorf J, Khunti K.  Hypoglycaemia awareness and the risk of severe hypoglycaemia in the global HAT study of 27,585 patients from 24 countries with type 1 and type 2 diabetes.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S1–S608 (721), DOI 10.1007/s00125-017-4350-z. PMID:28795195

124.Khunti K, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova M, Watada H, Shimomura I, Tang F, Ji L.  Factors associated with the discontinuation of metformin therapy: results from 11,539 patients in the global DISCOVER study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S420 (906), DOI 10.1007/s00125-017-4350-z. PMID:28795195

123.Shestakova M, Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Nicolucci A, Pocock S, Rathmann W, Watada H, Shimomura I, Tang F, Kosiborod M.  Global prevalence of type 2 diabetes complications in 14,391 patients initiating second-line therapy: the DISCOVER study.  53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon Portugal. Diabetologia (2017) 60 (Suppl 1):S518–S519 (1126), DOI 10.1007/s00125-017-4350-z. PMID:28795195

122.Mauricio D, Khunti K, Davies MJ, Westerbacka J, Cali A, Candelas C, Meneghini L. Achievement of Individual HbA1c Targets Set by the Physician in T2DM in a Real-World Setting According to the Risk of Hypoglycemia Complications.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A256-A257). 987-P.  Doi.org/10.2337/db17-890-1488

121.Cousminer D, Mishra R, Ahlovist E, Andersen M, Chesi A, Bradfield J, Pratley R, Rickels M, Vella A, Ovalle F, Harris R,Varvel S, Frogeul P, Lonsdale J, Mauricio D, Schloot N, Voight B, Hakonarson H, Khunti K, Greenbaum C, Asvold B, Yderstraede K, Pearson E, Scwartz S, Hansen T, Tuomi T, Boehm B, Groop L, Leslie D, Grant S.  First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Provides Novel Insights.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A48-A48). 181-OR. Doi.org/10.2337/db17-1-380

120.Kosiborod M, Arya N, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Kamal S, Nicolucci A, Pocock S, Rathmann W, Shestakova M, Shimomura I, Tang F, Watada H, Khunti K.  Global Prevalence of Type 2 Diabetes Complications in 14,391 Patients Initiating Second-Line Therapy: The DISCOVER Study.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A80-A80). 303-OR. Doi.org/10.2337/db17-1-380

119.Cavender M, Norhammar A, Birkeland K, Jorgensen M, Wilding J, Khunti K, Fu A, Bodegard J, Black B, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M, The CVD-REAL Investigators and study group.  Hospitalization for Heart Failure and Death in New Users of SGLT2 Inhibitors in Patients With and Without Cardiovascular Disease: CVD-REAL Study.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A99-A100). 377-OR. Doi.org/10.2337/db17-1-380

118. Pedersen-Bjergaard U, Aronson R, Gydesen H, Lekdorf J, Khunti K.  Hypoglycemia Awareness and the Risk of Severe Hypoglycemia in the Global HAT Study of 27,585 Patients with Type 1 and Type 2 Diabetes.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A587-A587). 2243-PUB. Doi.org/10.2337/db17-2235-2306

117. Meneghini L, Mauricio D, Orsi E, Lalic N, Cali A, Westerbacka J, Stella P, Candelas C, Pilorget V, Perfetti R, Khunti K.  Achievement of HbA1c Targets in the Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) Real-World Study.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A257-A258). 990-P. Doi.org/10.2337/db17-890-1488

116.Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Kamal S, Khunti K, Kosiborod M, Shestakova M, Shimomura I, Tang F, Watada H, Pocock S.  Treatment Patterns and Associated Factors in 13,379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study.  American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A326-A326). 1219-P. Doi.org/10.2337/db17-890-1488

115.Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes M, Hammar N, Ji L, Kamal S, Kosiborod M, Pocock S, Shestakova M, Shimomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in 14,005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study.   American Diabetes Association’s 77th Scientific Session. Diabetes 2017 Jun 1 (Vol. 66, pp. A447-A447). 1675-P. Doi.org/10.2337/db17-1489-1795

114. Zaccardi F, Webb D, Davies M, Dhalwani N, Gray L, Chatterjee S, Housley G, Shaw D, Hatton J, Khunti K. Predicting hospital stay, mortality, and readmission in people admitted for hypoglycaemia in England: prognostic models derivation and validation.  Diabetes UK Professional Conference 2017, Diabetic Medicine 34 (Suppl. s1), 141 – 144.  PMID:28271548

113.Dales J, Webb D, Dhalwani N, Zaccardi F, Griffin S, Wareham N, Khunti K, Davies M. Observational follow-up of a UK based screening programme for Type 2 diabetes. ADDITION Leicester.  Diabetes UK Professional Conference 2017, Diabetic Medicine 34 (Suppl. s1), 173 – 174.  PMID:28271548

112.Woolley A, Seidu S, Hadjiconstantinou M, Khunti K.  Online patient education in diabetes or cardiovascular disease: a systematic review of systematic reviews.    Diabetes UK Professional Conference 2017, Diabetic Medicine 34 (Suppl. s1), 114.  PMID:28271548

2016

111.Schofield D, Mitchell H, McGough S, Skinner T, Stribling B, Khunti K, Davies MJ.  Fidelity: The missing dimension in structured diabetes education around the globe. Diabetes Research & Clinical Practice, October 2016 Volume 120, Supplement 1, Page S60, DOI: http://dx.Doi.org/10.1016/S0168-8227(16)31047-6

110..Ray KK, Khunti K, Kondapally SSR, Pillas D, Addison J. Familial hypercholesterolaemia diagnosis: a case of missed opportunity. Congress of the European Society of Cardiology, 27-31 August, Rome, Italy, European Heart Journal. 37(Suppl 1), 1 August 2016; p. 9 (182).

109.Hambling CE, Seidu SI, Khunti K. Older people with type 2 diabetes are commonly overtreated with therapies associated with hypoglycaemia, even in the presence of chronic kidney disease. 52nd EASD Annual Meeting 12 – 16 September 2016 Munich, Germany. Abstract #827

108.Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Pocock S, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in  patients with type 2 diabetes: retrospective data from 22,272 individuals. 52nd EASD Annual Meeting 12 – 16 September 2016 Munich, Germany Abstract #897

107.Berard LD, Bonnemaire M, Mical M, Edelman S, Khunti K. Drivers of and barriers to optimal basal insulin (BI) titration: results of a quantitative survey. 52nd EASD Annual Meeting 12 – 16 September 2016 Munich, Germany. Abstract #910

106.Desai U, Kirson NY, Kim J, Khunti K, King SB, Trieschman E, Hellstern M, Hunt PR, Mukherjee J. Time to treatment intensification and its association with subsequent microvascular outcomes among patients with type 2 diabetes. 52nd EASD Annual Meeting 12 – 16 September 2016 Munich, Germany. Abstract # 1017

105.Berard LD, Polonsky WH, Bonnemaire M, Mical M, Edelman SV, Khunti K. Drivers of and Barriers to Optimal Basal Insulin (BI) Titration: Results of a Quantitative Survey. Diabetes 64(suppl 1) 972-P

104.Kîs GS, Khunti K, Maldonaldo M, del Parigi A, Gӧtz S, Lee C. Linagliptin (LINA) as Add-on to Empagliflozin (EMPA) and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Baseline Demographics in Two 24-Week Randomized, Double-Blind, Parallel-Group Trials. Diabetes 64(suppl 1): 1135-P

103.Heller SR, Cannon CP, Howitt H, Khunti K, Bergenstal RM, White WB, The Examine Investigators. Alogliptin in Triple Therapy with Metformin and Sulfonylureas Provides Significant Reductions in HbA1c and Is Well Tolerated: An Analysis from the EXAMINE Trial. Diabetes 64(suppl 1): 1149-P

102.Desai U, Kirson NY, Kim J, Khunti K, King SB, Trieschman E, Hellstern M, Hunt PR, Mukherjee J. Time to Treatment Intensification and Its Association with Subsequent Glycemic Control among Patients with Type 2 Diabetes. Diabetes 64(suppl 1) 1218-P

101.Pocock SJ, Charbonnel B, Gomes MB, Khunti K, Kosiborod MN, Nicolucci A, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal Glycaemic Control in Patients with Type 2 Diabetes: Retrospective Data from 22,272 Individuals. Diabetes 64(suppl 1) 1558-P

100.Jiang D, Ascher-Svanum H, van Brunt K, Kao CY, Fu H, Khunti K, Ghipetenanu G, Rodriguez A. Timely and Delayed Insulin initiation in People with Type 2 Diabetes in the United Kingdom: CPRD Database Analysis. Diabetes 64(suppl 1) 1645-P

99.Shur N, Major R, Papamargaritis D, Webb D, Khunti K, Shepherd D, Brunskill N. Assessment and management of risk factors in people with chronic kidney disease and diabetes mellitus multimorbidity. 53rd ERA-EDTA Congress. Nephrology Dialysis Transplantation. 01 May 2016; 31(Suppl 1):i69-i69.

98.Yates T, Edwardson CL, Khunti K, Rowlands AV, Davies MJ. Stability Of Self-reported And Objectively Assessed Physical Activity Over A 3 Year Period In Comparison To BMI. Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):756. [2701 Board #224 June 3, 11: 00 AM - 12: 30 PM]. DOI: 10.1249/01.mss.0000487270.14865.2d. PMID: 27361337

97.Rowlands AV, Fraysse F, Bakrania K, Yates T, Edwardson CL, Davies MJ, Khunti K, Olds TS. Tapping The Potential Presented By The Gravity Component Of An Accelerometer Signal. Med Sci Sports Exerc.2016 May;48(5 Suppl 1):782. [2780 Board #303 June 3, 9: 30 AM - 11: 00 AM]  DOI: 10.1249/01.mss.0000487349.79905.e5. PMID: 27361416

96..Edwardson C, Rowlands A, Harrington D, Plekhanova T, Harrington K, Yates T, Bodicoat D, Khunti K, Gorely T, Sherar L, Tudor-Edwards R, Davies M. The 'Girls Active' Physical Activity Intervention: Baseline Characteristics Of Objectively Measured Physical Activity. Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):918. [3215 Board #280 June 3, 2: 00 PM - 3: 30 PM] DOI: 10.1249/01.mss.0000487750.05700.fd. PMID: 27361784

95.Chalk TEW, Dunkley AJ, Gray LJ, Spong R, Gangadharan SK, Davies MJ, Khunti K. Lifestyle interventions for primary prevention of diabetes and cardiovascular disease in people with intellectual disabilities: a systematic review and meta-analysis. Diabetes UK Annual Conference 2016. Diabetic Medicine 33, 52-52 1 Mar 2016 (Suppl 1) P60.

94.Khunti K, Mohan V, Jain SM, Boesgaard TW, Begtrup K, Sethi BP. Efficacy and safety of a combination of insulin degludec + liraglutide (IDegLira) in people with Type 2 diabetes in India uncontrolled on oral antidiabetic drugs ± basal insulin were similar to the global DUAL phase 3 programme. Diabetes UK Annual Conference 2016. Diabetic Medicine 33, 61-61 01 Mar 2016 (Suppl 1) P89. PMID: 26931097

93.Chalk TEW, Dunkley AJ, Gray LJ, Spong R, Gangadharan SK, Davies MJ, Khunti K. Rates of Type 2 diabetes, cardiovascular disease and associated risk factors in people with intellectual disability populations: systematic review and meta-analysis. Diabetes UK Annual Conference. Diabetic Medicine 33, 73-74 1 Mar 2016 (Suppl 1) P129.

92..Barber SR, Dhalwani NN, Davies MJ, Khunti K, Gray LJ. Prospective validation of the Leicester/Diabetes UK Risk Assessment for diagnosis of Type 2 diabetes. Diabetes UK Annual Conference 2016. Diabetic Medicine 33, 30-30 1 Mar 2016 (Suppl 1) A71 (P254).

91.Sennett J, Campbell S, Sorensen J, Gray G, Leonard J, Davies M, Khunti K, Harvis J, Daly H. Diabetes training for healthcare assistants (HCAs) working in primary care (PC). Diabetes UK Annual Conference. Diabetic Medicine, 33, 131-131 1 Mar 2016(Suppl 1) P326.

90.Hambling CE, Seidu S, Khunti K. Elderly people with Type 2 diabetes and dementia are managed to similar glycaemic targets as those without dementia. Diabetes UK Annual Conference 2016. Diabetic Medicine 33, 143-43, 01 Mar 2016 (Suppl 1) P363. PMID: 26931097

89.Hambling CE, Seidu S, Khunti K. Overtreatment of older people with therapies associated with hypoglycaemia. Diabetes UK Annual Conference 2016. Diabetic Medicine 33, 143-143, 01 Mar 2016 (Suppl 1) P364. PMID: 26931097

88.Dunkley AJ, Spong R, Gray L, Tyrer F, Bhaumik S, Gangadharan SK, Davies MJ, Khunti K. Screening for people at high risk of Type 2 diabetes in a population with intellectual disabilities. Diabetes UK Annual Conference. Diabetic Medicine 3, 177-177 1 Mar 2016 (Suppl 1) P474.

87.Twigg S, Khunti K, Forst T, Janez A, Merion-Trigo A, Stella P, Grisoni ML, Galstyan G. Age of Diabetes Onset: Glycemic control and hypoglycemia benefit with new insulin glargine 300U/ML in T2DM. Diabetes Technology & Therapeutics 18, 110 3rd – 6th Feb 2016

86.Berard L, Polonsky W, Bonnemarie M, Edelman S, Khunti K. Communication between healthcare professionals (HCPS) and patients on basal insulin (BI) titration: Results of a quantitative survey. ADDT 9th International Conference. Diabetes Technology & Therapeutics 18, 296B 3rd - 6th Feb 2016


2015

85.Goldenberg R, Sobel J, Khunti K, Davies M, Vijapurkar U, Meininger G.  Incidence of GMI and UTI in patients with type 2 diabetes mellitus treated with canagliflozin over 2 years. International Diabetes Federation World Diabetes Congress, 30th November – 4th December. Vancouver, Canada. Abstract: 0377-P.

84.Khunti K, Patel S, Pfarr E, Lee C.  Consistent HbA1c changes with empagliflozin/linagliptin irrespective of body mass index, renal function or gender. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0378-P.

83. Aronson R, Galstyan G, Goldfracht M, Goldfracht M, Alsifri S, Elliott L, Kapur R, Khunti K.  Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0713-PD.

82. Pedersen-Bjergaard U, Alsifri S, Aronson R, Cigrovski Berković M, Galstyan G, Goldfracht M, Gydesen H, Lalic N, Ludvik B, Moberg E, Ramachandran A, Khunti K.  Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0943-PD.

81. Khunti K, Cigrovski Berković M, Geelhoed-Duijvestijn P, Ludvik B, Moberg E, Barner Lekdorf J, Gydesen H, Pedersen-Bjergaard U.  Regional variation in patient definitions and rates of hypoglycaemia in the global HAT study of 27,585 people on insulin. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0949-PD

80.Twigg S, Khunti K, Forst T, Janez A, Merino-Trigo A, Stella P, Grisoni M, Galstyan G.  Age of diabetes onset: Glycemic control and hypoglycemia benefit with new insulin glargine 300 U/mL in T2DM.  International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0357-PD

79.Khunti K, Jiang D, Ghimpeteanu G, Rodriguez A, Van Brunt K, Fu H, Ascher-Svanum H.  Glycemic outcomes in timely and delayed insulin-initiated patients with type 2 diabetes. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 0813-PD.

78. Davies MJ, Gray L, Ahrabian D, Leal J, Gray A, Troughton J, Tuomilehto J, Farooqi A, Khunti K, Yates T.  A community based primary prevention programme for type 2 diabetes in the UK: A cluster randomised controlled trial. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 1021-PD.

77. Khunti K. Tackling the diabetes epidemic among South Asians: Individual and population approach. International Diabetes Federation World Diabetes Congress, 30th November – 4th December, Vancouver, Canada. Abstract: 359.

76.Ashra N, Davies MJ, Khunti K.  Calculating the design effect for a cluster stepped-wedge trial with varying cluster size; a case study from a trial in type 2 diabetes. 3rd International Clinical Trials Methodology Conference, 16-17 November, Glasgow, UK. Trials 2015, 16(Suppl 2):P124. PMCID: PMC4660167

75.Taylor B, Danese M, Villa G, Lothgren M, Khunti K, Ray K. Rates of Cardiovascular Events in Patients Receiving High-Intensity Statin Therapy in the United Kingdom. The American Heart Association’s 2015 Scientific Sessions and Resuscitation Science Symposium. November 10. Circulation 132(Suppl 3) A18086.

74.Danese M, Gleeson M, Kutikova L, Griffiths R, Azough A, Khunti K, Kondapally SSR, Ray KK. Costs of Cardiovascular (CV) Events in the United Kingdom (UK) Using Real-World Data. ISPOR 19th Annual European Congress, 7th -11th November 2015. Milan, Italy. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 1 Nov 2015; 18(7):A387.

73.Danese M, Gleeson M, Kutikova L, Griffiths R, Khunti K, Kondapally SSR, Ray KK. Lipid Modifying Therapy Treatment Patterns and Cholesterol Control after Cardiovascular Events in the United Kingdom. ISPOR 19th Annual European Congress, 7th -11th November, Milan, Italy. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 7 Nov 2015; 18(7):A406. Doi.org/10.1016/j.jval.2015.09.953.

72.Mani H, Khunti K, Levy M, Bodicoat D, Gray L, Barnett J, Daly H, Howlett T, Davies MJ.  Structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome: SUCCESS-RCT improved physical activity and illness perception. Society for Endocrinology BES 2015, 2nd– 4th November, Edinburgh, UK. Endocrine Abstracts 38 P366 | DOI:10.1530/endoabs.38.P366

71.Hammar N, Charbonnel B, Fenici P, Garcia-Alvarez L, Gomes MB, Hashigami K, Hiller J, Ji L, Khunti K, Nicolucci A, Pocock S, Shestakova MV, Shimomura I, Surmont FA, and Medina J.  DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases. 51st EASD Annual Meeting, 14-18 September, Stockholm, Sweden. Diabetologia. 2015 Sep; 58 Suppl 1, pS188, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

70.Davies M, Sobel JD, Goldenberg RM, Khunti K, Vijapurkar U, Meininger G.  Incidence of genital mycotic infections decrease over time in patients with type 2 diabetes mellitus treated with canagliflozin over 2 years. 51st EASD Annual Meeting, 14-18 September, Stockholm, Sweden. Diabetologia. 2015 Sep; 58 Suppl 1, pS364, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

69.Pedersen-Bjergaard U, Alsifri S, Aronson R, Cigrovski Berkovic M, Galstyan G, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Ramachandran A, Khunti K.  Comparison of findings from the HAT study, the largest global hypoglycaemia study to date, with prior large real-world studies. 51st EASD Annual Meeting, 14-18 September 2015, Stockholm, Sweden. Diabetologia. 2015 Sep; 58 Suppl 1, pS458, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

68.Khunti K, Cigrovski Bergovic M, Geelhoed-Duijvestijn P, Ludvik B, Moberg E, Barner Lekdori J, Gydesen H, Pedersen-Bjergaard U.  Regional variation in patient definitions and rates of hypoglycaemia: findings from the HAT study of 27,585 people with type 1 and type 2 diabetes on insulin. 51st EASD Annual Meeting, 14-18 September, Stockholm, Sweden, Diabetologia. 2015 Sep; 58 Suppl 1, pS460, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

67.Mauricio D, Liao L, Wang H, Cali A, Stella P, Carita P, Khunti K. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe. 51st EASD Annual Meeting, 14-18 September, Stockholm, Sweden. Diabetologia. 2015 Sep; 58 Suppl 1, pS464, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

66.Elliott L, Aronson R, Galstyan G, Goldfracht M, Alsifri SN, Kapur RA, Khunti K.  Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. 51st EASD Annual Meeting, 14-18 September, Stockholm, Sweden. Diabetologia. Sep; 58 Suppl 1, pS480, DOI: 10.1007/s00125-015-3687-4.  PMID: 26264060

65.Aronson R, Galstyan G, Goldfracht M, Alsifri S, Elliot L, Kapur R, Khunti K, on behalf of the HAT Investigator Group.  Health Economic Impact of Hypoglycemia in a Global Population of Patients with Insulin-Treated Diabetes. 75th Scientific Sessions of the American Diabetes Association, 5-9 June 2015, Boston, USA. Diabetes. 2015 Jun; 64(Supplement 1): A1-A100. https://Doi.org/10.2337/db15-1-385. 263-OR

64.Davies MJ, Gray LJ, Goldby S, Hill S, Yates T, Khunti K, on behalf of the Let’s Prevent Diabetes Team.  A Community-based Primary Prevention Programme for Type 2 Diabetes in the UK: A Cluster Randomised Control Trial. 75th Scientific Sessions of the American Diabetes Association, 5-9 June 2015, Boston, USA. Diabetes. 2015 Jun; 64(Supplement 1): A187-A235. https://Doi.org/10.2337/db15-742-931. 744-P

63.Sobel J, Goldenberg R, Khunti K, Davies M,Vijapurkar, Meininger G.  Incidence of Genital Mycotic Infections Decreases over Time in Patients with Type 2 Diabetes treated with Canagliflozin over 2 Years. 75th Scientific Sessions of the American Diabetes Association, 5-9 June 2015, Boston, USA. Diabetes. 2015 Jun; 64(Supplement 1): A235-A382. https://Doi.org/10.2337/db15-932-1471. 1178-P

62. Ji L, Charbonnel B, Cook W, Fenici P, Garcia-Sanchez R, Gomes MB, Hammar N, Hashigami K, Khunti K, Nicolucci A, Shestakova MV, Shimomura I, Surmont FA, Medina J. A Global Study Program to Assess Real-World Evidence on Treatment and Outcomes of Patients with Type 2 Diabetes (T2D). Diabetes 2015 Jun; 64(Supplement 1): A677-A705. https://Doi.org/10.2337/db15-2683-2798. 2746-PO


2014

61.Khunti K, Alsifri S, Aronson R, Cigrovski Berković M, Enters-Weijnen C, Forsén T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A.  Self-reported hypoglycaemia: a global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study. 50th European Association for the Study of Diabetes (EASD) Annual Meeting, 15th – 19th September. Vienna, Austria. Diabetologia (2014) 57: [Suppl1] S1–S566.

60.Schernthaner G, Khunti K, Patel S, Cheng K, Mattheus M, Woerle H-J.  Safety of linagliptin in 8778 patients with type 2 diabetes mellitus: pooled analysis of 23 placebo-controlled randomised clinical trials. 50th European Association for the Study of Diabetes (EASD) Annual Meeting, 15th – 19th September, Vienna, Austria. Diabetologia (2014) 57: [Suppl1] S1–S566.

59.Greaves C, Dunkley A, Morris D,  Russell C, Yates T, Davies MJ, Khunti K.  Diabetes prevention in the real world: Systematic review and meta-analysis of the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of guideline recommendations on effectiveness. Presentation at ISBNPA Conference May 22nd 2014 and SAPC 2014 Conference, 9-11 July, Elevator pitch abstract, conference abstracts, p38, ref EP-1E.03

58.S Paul, K Kleine, A Majeed, K Khunti. Longitudinal Profiles of Blood Pressure, Lipids and HbA1c, and Their Association with Vascular and Mortality Risks in Patients with T2DM Under Cardioprotective Medications. American Diabetes Association (ADA) 74th Scientific Session, 13th – 17th June, San Francisco, California. Diabetes 63(Suppl1), A347 (1330-P)

57. Schernthaner G, Khunti K, Patel S, Cheng K, Mattheus M, Woerle H-J. Safety of Linagliptin in 8,778 Patients with Type 2 Diabetes Mellitus: Pooled Analysis of 23 Placebo-Controlled, Randomized Clinical Trials. American Diabetes Association (ADA) 74th Scientific Session, 13th – 17th June, San Francisco, California. Diabetes 63(Suppl1), 1081-P

56..Mostafa S, Khunti K, Bodicoat D, Webb D, Davies MJ.  Detecting vitamin D deficiency in South Asians: is a population or targeted method better? Society for Endocrinology BES 2014, 24th – 27th March, Liverpool, UK. Endocrine Abstracts (2014) 34 P115 | DOI:10.1530/endoabs.34.P115.

55..Mandalia P, Stone M, Carey M, Daly H, Hale R, Martin-Stacey L, Taub N, Khunti K, Gray L, Skinner T, Heller S, Davies MJ.  Acceptability of using trained lay people to deliver diabetes self-management education: a qualitative investigation using data from patients and educators. Diabetes UK Professional Conference 2014, 5-7 March, Arena and Convention Centre, Liverpool, UK. Diabetic Medicine 31:109-110 01 Mar 2014.  PMID: 24593688

54..Mostafa SA, Morris DH, Davies MJ, Srinivasan BT, Webb D, Khunti K. Equivalent glycaemic cut-points for the onset of microalbuminuria in White Europeans and South Asians: a cross-sectional analysis of a population based cohort. Diabetes UK Professional Conference 2014, 5-7 March, Arena and Convention Centre, Liverpool, UK. Diabetic Medicine 31:139-139 01 Mar 2014.  PMID: 24593688

53. Jamjoom BA, Bodicoat DH, Carter P, Mostafa S, Webb D, Khunti K, Davies MJ.  Use of anthropometric indices in predicting prevalent Type 2 diabetes in White European and South Asian adults in Leicestershire. Diabetes UK Professional Conference 2014, Arena and Convention Centre, 5-7 March, Liverpool, UK. Diabetic Medicine 31:16-16 01 Mar 2014.  PMID: 24593688

52.Barber SR, Davies MJ, Khunti K, Gray LJ.  Risk assessment tools for detecting those at high risk of type 2 diabetes: a systematic review. Diabetes UK Professional Conference 2014, Arena and Convention Centre, 5-7 March. Liverpool, UK. Diabetic Medicine, 2014, Mar, Vol 31 (Suppl. 1), p183.  PMID: 24593688

51. Butt A, Khunti K, Crasto W, and Davies MJ.  A systematic review examining the prevalence, progression and outcomes of foot ulcers and lower limb amputations in South Asians and White Europeans with type 2 diabetes. Diabetes UK Professional Conference 2014, Arena and Convention Centre, 5-7 March, Liverpool, UK. Diabetic Medicine, 2014, Mar, 31 (Suppl. 1), p121, P315.  PMID: 24593688

2013

50.Mostafa SA, Khunti K, Morris DH, Webb DR, Srinivasan BT, & Davies MJ. Is the use of statin therapy associated with higher risk of progression from high risk states to Type 2 diabetes over four years? Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), A15 (P573) PMID: 23600920 DOI: 10.1111/dme.12090_1

49.Wilmot E, Leggate M, Khan JN, Gorely T, Khunti K, Kuijer JPA, van Rossum AC, Singh A, Yates T, Nimmo M, McCann G, Davies MJ.  Type 2 diabetes mellitus in young adults: An extreme phenotype with early cardiovascular dysfunction. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), A57 (P192) PMID: 23600920 DOI: 10.1111/dme.12090_1

48.Heller S, Dallosso HM, Hadjiconstanitou M, Morris D, Speight J, Campbell M, Carey M, Daly H, Martin-Stacey L, Khunti K, Davies MJ.  Does self-monitoring of blood glucose as opposed to urinalysis provide additional benefit in people with newly diagnosed type 2 diabetes receiving structured education? A cluster randomised controlled trial. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P133 PMID: 23600920 DOI: 10.1111/dme.12090_1

47.Mostafa SA, Davies MJ, Morris DH, Webb DR, Srinivasan BT, Khunti K. Do baseline Vitamin D levels independently predict 4-year progression from prediabetes to Type 2 Diabetes? Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P157 PMID: 23600920 DOI: 10.1111/dme.12090_1

46.Stone MA, Patel N, Amin S, Daly H, Carey M, Davies MJ, Khunti K. Development and evaluation of a Type 2 diabetes specific cultural competency training module for healthcare providers. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P287 PMID: 23600920 DOI: 10.1111/dme.12090_1

45.Eborall HC, McNichol S, Dallosso HM, Speight J, Daly H, Martin-Stacey L, Carey ME, Davies MJ, Khunti K.  Explaining engagement in self-monitoring of blood glucose and urinalysis among participants of the DESMOND SMBG trial: A qualitative interview study. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P332 PMID: 23600920 DOI: 10.1111/dme.12090_1

44..Seidu S, Davies M, Mostafa SA, de Lusignan S, & Khunti K. Prevalence and characteristics in coding, classification and diagnosis of diabetes in primary care. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P538 PMID: 23600920 DOI: 10.1111/dme.12090_1

43.Stone MA, Aujla N, Khunti K. Adherence to recommendations for the management of Type 2 diabetes: how does the UK compare with other European countries involved in the Guideline Adherence to Enhance Care (GUIDANCE) study? Abstract/Poster at the Diabetes UK Professional Conference 2013, Manchester Central Convention Complex, Manchester, UK, 13-15 March, Diabetic Medicine. 30(Suppl1), P539 PMID: 23600920 DOI: 10.1111/dme.12090_1

42.Wilmot EG, Edwardson CL, Biddle SJH, Gorely T, Henson JJ, Khunti K, Davies MJ. Prevalence of diabetes and impaired glucose tolerance in younger UK adults. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), P571 PMID: 23600920 DOI: 10.1111/dme.12090_1

41.Davies MJ, Khunti K, and Lin J (2013). Glycaemic target attainments with lixisenatide, a new once-daily glucagon-like peptide (GLP-1) receptor agonist, as add-on to oral hyperglycaemic agents or basal insulin in type 2 diabetes: a regression analysis of pooled phase 3 clinical trial data. Abstract/Poster at the Diabetes UK Professional Conference 2013, 13-15 March, Manchester, UK. Diabetic Medicine. 30(Suppl1), pE7, P590. DOI: 10.1111/dme.12115. PMID: 23683104 PMID: 23600920 DOI: 10.1111/dme.12090_1

40.Mani H, Levy M, Davies MJ, Morris D, Gray L, Bankhart J, Blackledge H, Khunti K, Howlett T. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20 year retrospective cohort study. Spring Meeting for Clinician Scientists in Training, Lancet 381: S70. 27 February 2013

39.Mani H, Daly H, Barnett J, Levy M, Khunti K, Howlett T, Davies MJ. The development of a structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome; the SUCCESS study. Abstracts from Society for Endocrinology BES 2013, 18 – 21 March, Harrogate, UK. Endocrine Abstracts (2013) 31 P228 DOI:10.1530/endoabs.31.P228

38.Mani H, Morris D, Levy M, Davies MJ, Gray L, Blackledge H, Khunti K, Howlett T. Effect of ethnicity on the clinical presentation of women with polycystic ovary syndrome; a 20 year retrospective cohort study. Abstracts from Society for Endocrinology BES 2013, 18 – 21 March, Harrogate, UK. Endocrine Abstracts (2013) 31 P308 DOI:10.1530/endoabs.31.P308

37.Khan JN, Wilmot E, Davies MJ, Gorely T, Khunti K, Leggate M, Nimmo M, Singh A, Yates T, McCann GP.  Detection and potential mechanisms of subclinical left ventricular dysfunction in asymptomatic young adults with type-2 diabetes. Abstracts of the 16th Annual SCMR Scientific Sessions, 31 January - 3 February, San Francisco, CA, USA. Journal of Cardiovascular Magnetic Resonance 15;(suppl 1), O48

36..Greaves C, Dunkley A, Bodicoat D, Russell C, Yates T, Davies MJ, Khunti K.  Diabetes prevention in the real world: Systematic review and meta-analysis of the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of guideline recommendations on effectiveness. UK Society for Behavioural Medicine 2013, 9th Annual Scientific Meeting, 9-10 Dec, Oxford.

35..Davies MJ, Brady EM, Gray LJ, Saeed MA, Hanif W, Khunti K.  Treat 4 Ramadan: Randomised Controlled Trial Comparing Liraglutide with a Sulphonylurea added to Metformin in Established Type 2 Diabetes. International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia, PD-0674.

34.Khunti K, Enters-Weijnen C, Geelhoed-Duijvestijn P, Forsen T, Pedersen-Bjergaard U, Moberg E, Kapur R, Gydesen H, Ludvik B. Hypoglycaemia among insulin-treated patients with diabetes: an international retrospective and prospective study of 3832 patients. International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia, P-1775.

33.Gallwitz B, Benhamou PY, Charpentier G, Consoli A, Diamant M, Khunti K, Mathieu C, Ridderstrale M, Seufert J, Tack C, Vilsboll T, Javier Ampudia-Blasco. Recommendations for individualised medical treatment of hyperglycaemia in type 2 diabetes: a systematic analysis of expert opinion. International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia, P-1055.

32.Vora J, Caputo S, Damci T, Orozco-Beltran D, Pan C, Svendsen AL, Sojle KS, Khunti. . Effects of once-daily insulin detemir on oral anti0diabetic drug (OAD) use in patients with type 2 diabetes. International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia, P-1415.

31.Mitchell H, Schofield D, Stribling B, Davies MJ, Khunti K, Skinner TC.  DESMOND Down Under: the benefits of quality improvement for structured diabetes self management programs in Western Australia. International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia, P-1676.

30.Zafar A, Stone M, Davies MJ, Khunti K. Qualitative study to explore the barriers faced by primary care health professionals in the management of type 2 diabetes mellitus (T2DM). International Diabetes Federation (IDF) World Diabetes Congress 2013, 2-6 December, Melbourne, Australia. - P1280

29.Chubb B, Evans M, Jensen HH, Bøgelund M, Gundgaard J, Khunti K.  Flexible insulin dosing improves health-related quality of life (HRQoL): a time trade-off survey. Abstracts of the 49th EASD (European Association for the Study of Diabetes) Annual Meeting. September 23-27, 2013. Barcelona, Spain. Diabetologia (2013) 56: [Suppl1] p S466, P1160. DOI: 10.1007/s00125-013-3012-z.  PMID: 23949610

28.Brady EM, Davies MJ, Gray LJ, Saeed MA, Hanif W, Khunti K.  Treat 4 Ramadan: Randomised Controlled Trial Comparing Liraglutide with a Sulphonylurea added to Metformin in Established Type 2 Diabetes. Abstracts of the 49th EASD (European Association for the Study of Diabetes) Annual Meeting. September 23-27, 2013. Barcelona, Spain. Diabetologia (2013) 56: [Suppl1], p S371, P928.  PMID: 23949610

27.Paul S, Thorsted BL, Wolden M, Klein K, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with Type 2 Diabetes. Abstracts of the 49th EASD (European Association for the Study of Diabetes) Annual Meeting. September 23-27, 2013. Barcelona, Spain. Diabetologia (2013) 56: [Suppl1], p S534, P1338.  PMID: 23949610


2012

26.Castro M, Dequen P, Davies MJ, Khunti K, Abrams KR. Assessing Interventions For Adults With Metabolic Syndrome: A Comprehensive Economic Markov Decision Model. ISPOR 17th Annual International Meeting June 2012. Value in Health: 15(4); A104 (PSY34)

25.Dunkley AJ, Davies MJ, Stone MA, Taub NA, Troughton J, Yates T and Khunti K. Effectiveness of lifestyle education for reducing diabetes and cardiovascular risk in people with metabolic syndrome. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) A23 page 9

24.Carey ME, Mandalia P, Cradock S, Daly H, Doherty Y, Gray L, Hale R, Heller S, Khunti K, Kilgallen G, Stacey LM, Phillips J, Skinner TC, Stone MA, Taub NA, Taylor C and Davies MJ.  The DESMOND Lay Educator study: testing a training programme for lay educators to deliver the DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) programme in partnership with healthcare professional educators. Diabetic Medicine 2012; 29(Suppl 1) A55 page 19.

23.Vora J, Khunti K, Yale J-F, Meneghini LF.  Clinical inertia in people with Type 2 diabetes before insulin initiation in routine clinical practice in the UK versus a global cohort: baseline data from the SOLVETM study. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) A65 page 23.

22.Castro M, Abrams K, Davies MJ, Willis A, and Khunti K. Metabolic syndrome and risk of cardiovascular disease, diabetes and mortality. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland, Diabetic Medicine 2012; 29(Suppl 1) P34 page 39.

21.Quinn LM, Carter P, Gray LJ, Khunti K, Webb D and Davies MJ.  Association of serum potassium levels to two-hour blood glucose: ADDITION Leicester. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P56 page 45.

20..Mostafa SA, Davies MJ, Gray LJ, Webb DR, Srinivasan BT and Khunti K. Trajectories of glycated haemoglobin, HbA1c, in people with impaired glucose regulation developing diabetes or reverting to normal glucose regulation. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P58 page45.

19.Mostafa SA, Davies MJ, Webb DR, Srinivasan BT, Gray LJ, and Khunti K. The association between triglyceride-to-HDL ratio and insulin resistance: a cross-sectional analysis of a UK multi-ethnic cohort. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P59 page 46.

18.Carter P, Brady EM, Talha E, Al-Rmalli S, Jenkins RO, Gray LJ, Khunti K, Davies MJ, and Haris PI.  Plasma selenium levels in South Asian and White European individuals. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P60 page 46.

17.Webb DR, Gray LJ, Khunti K, Farooqi A, Davies MJ.  Estimating absolute cardiovascular risk reduction in young South Asians with newly diagnosed glucose disorders. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P157 page 79.

16.Davies MJ, Achana FA, Carter P, Troughton J, Gray LJ, Khunti K. Effect of Mediterranean diet on fasting glucose compared with other dietary interventions: a network meta-analysis. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P196 page 90

15.Dunkley AJ, Stone MA, Fisher H, Davies MJ, Khunti K. Acceptability of lifestyle education for people with metabolic syndrome: a qualitative evaluation. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P238 page 101.

14.Khunti K and Vora J.  Study of Once-daily LeVemir (SOLVETM): UK results from a 24-week international observational study. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P368 page 141.

13.Mani H, Davies MJ, Howlett TA, Levy MJ, Gray LJ, Bankart MJ, Blackledge H, Khunti K. Association of Type 2 diabetes with polycystic ovary syndrome: analysis of a large cohort of patients with polycystic ovary syndrome. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland. Diabetic Medicine 2012; 29(Suppl 1) P446 page165.

12.Patel N, Stone MA, Eborall H, McDonough C, Davies MJ, Khunti K. Barriers to insulin therapy in people with Type 2 diabetes: a qualitative exploration of attitudes in a multi-ethnic population. Diabetes UK Professional Conference 2012, 7- 9 March, Scottish Exhibition & Conference Centre (SECC), Glasgow, Scotland, Diabetic Medicine 2012; 29(Suppl 1) P485 page 176

11.Gundgaard J, Harris SB, Evans M, Khunti K, Mamdani M, Galbo-Jørgensen CB, Bøgelund M.  Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey. 48th EASD (European Association for the Study of Diabetes) Annual Meeting, 1-5 October, Berlin, Germany. Diabetologia 2012; 55(Suppl 1) 228 page S101.

10.Mostafa SA, Khunti K, Morris DH, Webb D, Srinivasan BT, Davies MJ.  Can liver enzymes predict progression from prediabetes to type 2 diabetes independent of factors associated with the metabolic syndrome in White Europeans and South Asians? 48th EASD (European Association for the Study of Diabetes) Annual Meeting, 1-5 October, Berlin, Germany, Diabetologia 2012; 55(Suppl 1) 311 page S135.

9..Khunti K, Fisher H, Paul S, Mohammad I, Davies MJ, Siriwardena AN.  Characteristics and costs of individuals experiencing severe hypoglycaemia requiring emergency ambulance assistance in the community. 48th EASD (European Association for the Study of Diabetes) Annual Meeting, 1-5 October, Berlin, Germany. Diabetologia 2012; 55(Suppl 1) 621 page S255.

8.. Mani H, Davies M, Levy M, Blackledge H, Gray L, Howlett T, Khunti K. Increased cardiovascular events in women with Polycystic Ovary Syndrome: retrospective analysis of a large database. Abstracts from Society for Endocrinology BES 2012, 18 – 22 March, Harrogate, UK, Endocrine Abstracts 28 OC2.7

7.Khan JN, Wilmot EG, Leggate M, Singh A, Yates T, Nimmo MA, Khunti K, Horsfield MA, Plein S, Biglands J, Van Rossum A, Clarysse P, Croisille P, Davies M, McCann GP.  Subclinical cardiac dysfunction in young adults with Type-2 Diabetes: A pilot CMR study assessing potential mechanisms. 7th Meeting BSCMR (British Society of Cardiovascular Magnetic Resonance), 14 March, New Queen Elizabeth Hospital, Birmingham, UK,

6. Jain A, Evans M, Khunti K, Mamdani M, Harris SB, Galbo-Jørgensen C, Gundgaard J, Bøgelund M.  Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey. National Diabetes Institute ‘Diabetes Asia 2012’ Conference and Workshop, 17 – 21 October, Hotel Istana, Kuala Lumpur, Malaysia,

5.Evans M, Khunti K, Mamdani M, Harris SB, Galbo-Jørgensen C, Gundgaard J, Bøgelund M.  Health-Related Quality of Life Associated with Daytime and Nocturnal Hypoglycaemic Events: a Time Trade-Off Survey. 72nd Scientific Session of the American Diabetes Association 2012 Jun Diabetes 61(Suppl 1):135-OR. PMID: 22701883

4.S Paul, K Klein, G Thomas, K Khunti. Blood pressure trajectories before death in patients with type 2 diabetes. 72nd Scientific Session of the American Diabetes Association 2012 Jun Diabetes 61(Suppl 1):433-P. PMID: 22701883

3..S Paul, JH Best, K Khunti, K Klein. Five-Year Population Level Trajectory of HbA1c (AIC) and its Association with Mortality in Patients with Type 2 Diabetes (T2DM). 72nd Scientific Session of the American Diabetes Association 2012 Jun Diabetes 61(Suppl 1): 1394-P. PMID:22701883

2.Parekh S, Morris DH, Khunti K, Mani H, Mostafa S, Webb DR, Gray L, Davies M. Determinants of Reactive Hypoglycemia (RH): Analysis of a Cohort of 6,749 People from a UK Multiethnic Population. 72nd Scientific Session of the American Diabetes Association 2012 Jun Diabetes 61(Suppl 1) 1445-P. PMID: 22701883

1.Webb DR, Khunti K, Davies M. An Adverse Adiponectin Profile Does Not Associate with Insulin Resistance in British South Asians. 72nd Scientific Session of the American Diabetes Association 2012 Jun Diabetes 61(Suppl 1) 1690-P. PMID: 22701883

Share this page:

Navigation

shanghairanking-sm.jpg